Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Stotani

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|April 14, 2016
DYRK1A inhibition as potential treatment for Alzheimer's diseaseSilvia Stotani, Fabrizio Giordanetto, Federico Medda
Organic Letters|April 1, 2015
Efficient isocyanide-less isocyanide-based multicomponent reactionsConstantinos G Neochoritis, Silvia Stotani, Bhupendra Mishra, et al.
ACS Combinatorial Science|July 31, 2015
Leuckart-Wallach Route Toward Isocyanides and Some ApplicationsConstantinos G Neochoritis, Tryfon Zarganes-Tzitzikas, Silvia Stotani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2019
Interrogating dense ligand chemical space with a forward-synthetic libraryFlorent Chevillard, Silvia Stotani, Anna Karawajczyk, et al.
Molecules (Basel, Switzerland)|October 11, 2018
A Versatile Strategy for the Synthesis of 4,5-Dihydroxy-2,3-Pentanedione (DPD) and Related Compounds as Potential Modulators of Bacterial Quorum SensingSilvia Stotani, Viviana Gatta, Federico Medda, et al.
Journal of Medicinal Chemistry|February 21, 2019
DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial ResistanceSilvia Stotani, Viviana Gatta, Prasanthi Medarametla, et al.
ACS Combinatorial Science|May 11, 2016
Design and Synthesis of Fsp(3)-Rich, Bis-Spirocyclic-Based Compound Libraries for Biological ScreeningSilvia Stotani, Christoph Lorenz, Matthias Winkler, et al.
Future Medicinal Chemistry|October 28, 2017
Are sigma receptor modulators a weapon against multiple sclerosis disease?Simona Collina, Marta Rui, Silvia Stotani, et al.
Frontiers in Chemistry|July 23, 2020
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (<i>E</i>)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer AgentsRoberta Listro, Silvia Stotani, Giacomo Rossino, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|April 14, 2016
DYRK1A inhibition as potential treatment for Alzheimer's diseaseSilvia Stotani, Fabrizio Giordanetto, Federico Medda
Organic Letters|April 1, 2015
Efficient isocyanide-less isocyanide-based multicomponent reactionsConstantinos G Neochoritis, Silvia Stotani, Bhupendra Mishra, et al.
ACS Combinatorial Science|July 31, 2015
Leuckart-Wallach Route Toward Isocyanides and Some ApplicationsConstantinos G Neochoritis, Tryfon Zarganes-Tzitzikas, Silvia Stotani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2019
Interrogating dense ligand chemical space with a forward-synthetic libraryFlorent Chevillard, Silvia Stotani, Anna Karawajczyk, et al.
Molecules (Basel, Switzerland)|October 11, 2018
A Versatile Strategy for the Synthesis of 4,5-Dihydroxy-2,3-Pentanedione (DPD) and Related Compounds as Potential Modulators of Bacterial Quorum SensingSilvia Stotani, Viviana Gatta, Federico Medda, et al.
Journal of Medicinal Chemistry|February 21, 2019
DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial ResistanceSilvia Stotani, Viviana Gatta, Prasanthi Medarametla, et al.
ACS Combinatorial Science|May 11, 2016
Design and Synthesis of Fsp(3)-Rich, Bis-Spirocyclic-Based Compound Libraries for Biological ScreeningSilvia Stotani, Christoph Lorenz, Matthias Winkler, et al.
Future Medicinal Chemistry|October 28, 2017
Are sigma receptor modulators a weapon against multiple sclerosis disease?Simona Collina, Marta Rui, Silvia Stotani, et al.
Frontiers in Chemistry|July 23, 2020
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (<i>E</i>)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer AgentsRoberta Listro, Silvia Stotani, Giacomo Rossino, et al.
Pageof 1